BioLineRx (BLRX) Change in Accured Expenses (2018 - 2025)
BioLineRx's (BLRX) quarterly Change in Accured Expenses came in at -$568000.0 in Q3 2025, up 3.07% year-on-year from -$551072.8 in Q3 2024, and down 2372.0% quarter-over-quarter from $25000.0 in Q2 2025.
BioLineRx (BLRX) Change in Accured Expenses (2018 - 2025) Analysis & Trends
BioLineRx's Change in Accured Expenses history runs 6 years deep, the most recent figure standing at -$568000.0 for Q3 2025.
- On a quarterly basis, Change in Accured Expenses rose 3.07% year-over-year to -$568000.0 in Q3 2025; TTM through Sep 2025 was -$3.6 million, a 39.79% increase from a year earlier, with the FY2013 full-year figure at -$3.9 million, changed N/A from the prior year.
- Change in Accured Expenses eased to -$568000.0 in Q3 2025 per BLRX's latest filing, from $25000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $180000.0 in Q3 2021 and bottomed at -$3.5 million in Q1 2024.
- The 3-year median for Change in Accured Expenses is -$568000.0 (2025), against an average of -$1.1 million.
- Biggest YoY gain for Change in Accured Expenses was 113.34% in 2021; the steepest drop was 243.38% in 2021.
- Year by year, Change in Accured Expenses stood at $180000.0 in 2021, then tumbled by 425.56% to -$586000.0 in 2024, then advanced by 3.07% to -$568000.0 in 2025.
- Per Business Quant, the three latest BLRX Change in Accured Expenses figures stand at -$568000.0 (Q3 2025), $25000.0 (Q2 2025), and -$2.5 million (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -16.82 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -16.74 Mn |
| 10 | BioLineRx | 7.05 Bn | 7.06 Bn | 154,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -568,000.00 |
| Sep 30, 2025 | -568,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Mar 31, 2025 | -2.51 Mn |
| Mar 31, 2025 | -2.51 Mn |
| Sep 30, 2024 | -586,000.00 |
| Sep 30, 2024 | -586,000.00 |
| Jun 30, 2024 | -2.12 Mn |
| Jun 30, 2024 | -2.12 Mn |
| Mar 31, 2024 | -3.51 Mn |
| Mar 31, 2024 | -3.51 Mn |
| Sep 30, 2021 | 180,000.00 |
| Sep 30, 2021 | 180,000.00 |
| Jun 30, 2021 | -467,000.00 |
| Jun 30, 2021 | -467,000.00 |
| Mar 31, 2021 | -502,000.00 |
| Mar 31, 2021 | -502,000.00 |
| Sep 30, 2020 | -1.35 Mn |
| Sep 30, 2020 | -1.35 Mn |